Oxlumo

FDA approves label expansion of Alnylam’s Oxlumo for PH1
Pharmaceutical Business Review
Fri, 10/7/22 - 10:38 am
Alnylam
FDAA
Oxlumo
advanced primary hyperoxaluria
PH1
Alnylam provides long-term look at Oxlumo, aiming to further carve out stake in PH1 market
Endpoints
Tue, 05/4/21 - 10:38 am
Alnylam
Oxlumo
Primary Hyperoxaluria
clinical trials